An insight into interventional bronchoscopy
- PMID: 40334941
- PMCID: PMC12151668
- DOI: 10.1016/j.clinme.2025.100321
An insight into interventional bronchoscopy
Abstract
The emergent field of interventional bronchoscopy provides an alternative approach for the diagnosis and management of a range of respiratory conditions. Within malignant disease, robotic navigational bronchoscopy provides a stable platform to sample small and difficult to reach pulmonary nodules, while malignant central airway obstruction can be managed through transcopic stent insertion. A range of therapeutic modalities have been developed for benign disease, which provide alternatives to standard therapy, particularly in the context of endobronchial valves for chronic obstructive pulmonary disease, and bronchial thermoplasty for asthma, while transbronchial cryoexcision lung biopsy offers a non-surgical option for undiagnosed interstitial lung disease. With a rich pipeline of technology being developed through robust clinical trial processes, the field of interventional bronchoscopy will continue to grow to become an invaluable asset, not only to the field of respiratory medicine, but to the general physician.
Keywords: Airways stent; Bronchoscopy; Cryobiopsy; Endobronchial valves; Robotic navigation bronchoscopy.
Copyright © 2025. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Pallav L Shah reports a relationship with Ambu Inc that includes: consulting or advisory. Pallav L Shah reports a relationship with Olympus Europa SE & Co KG that includes: consulting or advisory. Pallav L Shah reports a relationship with Creo Medical that includes: consulting or advisory. Pallav L Shah reports a relationship with Pulmonx Corp that includes: speaking and lecture fees. Christopher M Orton reports a relationship with Pulmonx Corp that includes: consulting or advisory. Christopher M Orton reports a relationship with Intuitive Surgical Inc that includes: consulting or advisory. P.L. Shah is an investigator on clinical trials conducted by Pulmonx, Nuvaira, CSA Medical, Creo Medical, Apreo, Galavanize Therapeutics, Intuitive, SNIPE and Huma. C.M. Orton is an investigator on clinical trials conducted by Pulmonx, Nuvaira, CSA Medical, Creo Medical, Apreo, Galavanize Therapeutics, Intuitive and SNIPE. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Panchabhai T.S., Mehta AC. Historical perspectives of bronchoscopy. Connecting the dots. Ann Am Thorac Soc. 2015;12(5):631–641. - PubMed
-
- Fitzmaurice C., Abate D., Abbasi N., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the Global burden of Disease study. JAMA Oncol. 2019;5(12):1749–1768. - PMC - PubMed
-
- Emily Lawson RS, Peter Johnson. Cancer programme update 2025 [Available from: https://www.england.nhs.uk/long-read/cancer-programme-update/. Accessed May 18, 2025.
-
- Chan L.T., Orton C.M., Shah PL. A new dawn for bronchoscopy for peripheral lung lesions? Chest. 2024;166(5):931–933. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
